Issuu on Google+

ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email!

Future US Microbiology Testing Market Outlook Published on February 2012

Report Summary

Complete report $9,400. DataPack (test volumes, sales forecasts, supplier shares) $3,450. HighlightsComprehensive 1,037-page analysis of the US microbiology testing market.Major issues pertaining to the US microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms.Ten-year test volume and sales forecasts for nearly 80 microbiology tests performed in US hospitals, blood banks, physician offices, public health and commercial laboratories.Instrumentation technologies and feature comparison of leading analyzers.Sales and market shares of leading suppliers.Emerging diagnostic technologies and their potential market applications.Product development opportunities.Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.Business opportunities and strategic recommendations for suppliers. Contains 1,037 pages and 177 tables

Table of Content US MICROBIOLOGY TESTING MARKET Table of Contents Introduction Worldwide Market and Technology Overview A. Major Infectious Disease Tests 1. AIDS a. Background 0 Structure and Composition 0 Classification 0 Origin of AIDS 0 Animal Lentivirus Systems 0 Virus Receptos 0 HIV Infections in Humans - Pathogenesis & Pathology: Overview of HIV Infection Course 0 CD4T Lymphocytes and Memory Cells 0 Monocytes and Macrophages 0 Lymphoid Organs 0 Neural Cells 0 Viral Coinfections

Future US Microbiology Testing Market Outlook (From Issuu)

Page 1/28


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! - Clinical Findings 0 Plasma Viral Load 0 Pediatric AIDS - Neurologic Disease - Opportunistic Infections - Cancer 0 Immunity - Virus Isolation - Serology - Detection of Viral Nucleic Acid and Antigens 0 Infectivity 0 Epidemiology - Worldwide Spread of AIDS - United States - Routes of Transmission b. Diagnostic Tests 0 Laboratory Diagnosis - Enzyme Immunoassay Interpretation - Specific, Sensitivity, and Predictive Value of Enzyme Immunoassays 0 Competition Assays 0 Western Blot Technique 0 Immuno-Fluorescence Assay (IFA) 0 Radioimmunoprecipitation 0 HIV-1/HIV-2 Combination Testing 0 Methods of HIV-Antigen Detection 0 Antigen Assays and Blood Screening 0 Urine Tests 0 Immunopathogenic Mechanism of HIV Infection 0 DNA Probes - Overview - Quantitative Polymerase Chain Reaction - In Situ PCR - Needed Improvements 0 Viral Load/Drug Resistance Testing 0 Genotype and Phenotype Testing 0 Blood Banking Consideration c. Vaccines and Drugs - Antiviral Drugs - Vaccines Against HIV 0 Transmission of HIV in Blood Products 0 HIV Transmission in Transplant and Artificial Insemination Recipients 2. Adenovirus a. Background b. Diagnostic Tests

Future US Microbiology Testing Market Outlook (From Issuu)

Page 2/28


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! c. Vaccines and Drugs d. Adeno-Associated Viruses(AAV) 3. Aeromonas a. Background b. Diagnostic Tests c. Vaccines and Drugs 4. Anthrax/Bacillus Anthracis a. Background b. Diagnostic Tests c. Vaccines and Drugs 5. Arboviruses a. Background b. Diagnostic Tests c. Vaccines and Drugs 6. Babesiosis a. Background 7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea) a. Background b. Diagnostic Tests c. Vaccines and Drugs 8. Blastocystis Hominis a. Background b. Diagnostic Tests c. Vaccines and Drugs 9. Brucella a. Background b. Diagnostic Tests c. Vaccines and Drugs 10. Campylobacter a. Background b. Diagnostic Tests 0 Identification from Culture c. Vaccines and Drugs 11. Candida a. Background b. Diagnostic Tests c. Vaccines and Drugs 12. Chagas Disease a. Background 13. Chancroid a. Background b. Diagnostic Tests c. Vaccines and Drugs 14. Chlamydia a. Background 0 Chlamydia Psittaci

Future US Microbiology Testing Market Outlook (From Issuu)

Page 3/28


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! 0 Chlamydia Pneumoniae 0 Chlamydia Trachomatis b. Diagnostic Tests c. Vaccines and Drugs 15. Clostridium Difficile a. Background 0 Pediatric Infections 0 Epidemiology b. Diagnostic Tests 0 Counterimmunoelectrophoresis 0 Fluorescent-Antibody Assays 0 Poloymerase Chain Reactions c. Drugs and Vaccines 16. Coronaviruses a. Background b. Diagnostic Tests c. Vaccines and Drugs 17. Coxsackieviruses a. Background 0 Herpangina 0 Hand-foot-and-mouth syndrome 0 Hepidemic Conjuctivitis 0 Pharingitis 0 Epidemic Pleurodynia 0 Myodarditis,Pericarditis 0 Overwhelming Infection of the Newborn 0 Acute Aseptic Meningitis 0 Undifferentiated Febrile Illness 0 Fever with upper respiratory infection 0 Encephalitis 0 Asymptomatic Infection b. Diagnostic Tests c. Vaccines and Drugs 18. Creutzfeldt-Jakob's Disease a. Background 0 Blood Transmission b. Diagnostic Tests 0 Major Commercial and Academic Players - Bayer - Disease Sciences/Bio Tec Global - Imperial College of Medicine - Ortho-Clinical Diagnostics - Pall - ProMetic Life Sciences - Proteome Sciences/Idexx - Q-One Biotech - Serono

Future US Microbiology Testing Market Outlook (From Issuu)

Page 4/28


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! - U.S. Agricultural Research Service c. Vaccines 19. Cryptosporidium Parvum a. Background b. Diagnostic Tests 0 Histologic 0 Laboratory Parasitology 0 Serodiagnosis c. Vaccines and Drugs 20. Cyclospora Cayetanensis a. Background 0 Asymptomatic Infection 0 Diarrhea in Immunocompetent Persons 0 Diarrhea in Immunocompromisedersons b. Diagnostic Tests c. Vaccines and Drugs 21. Cytomegalovirus a. Background 0 Chorioretinitis 0 Gastrointestinal 0 Central Nervous System Disease b. Diagnostic Tests c. Vaccines and Drugs 22. Ebola Virus a. Background 0 Epidemiology 0 Hemorrhagic Fever b. Diagnostic Tests c. Vaccines and Drugs 23. E. Coli a. Background 0 Role of Escherichia Coli in Causing Diarrhea 0 EPEC 0 ETEC 0 EIEC 0 EHEC b. Diagnostic Tests c. Vaccines and Drugs 24. EchoVirus a. Background 0 Acute Aseptic Miningitisis 0 Encephalitis 0 Exanthems 0 Respiratory Disease 0 Myope;ricarditis 0 Neonatal Infections

Future US Microbiology Testing Market Outlook (From Issuu)

Page 5/28


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! b. Diagnostic Tests c. Vaccines and Drugs 25. Encephalitis a. Background b. Diagnostic Tests c. Vaccines and Drugs 26. Enteroviruses a. Background b. Diagnostic Tests 0 Viral Isolation and Identification 0 Antibody Tests c. Vaccines and Drugs 27. Epstein-Barr Virus a. Background b. Diagnostic Tests c. Vaccines and Drugs 28. Giardia Lamblia a. Background 0 Life Cycle and Morphology 0 Morphology of Trophozoites 0 Clinical Disease b. Diagnostic Tests c. Vaccines and Drugs 29. Gonorrhea a. Background b. Diagnostic Tests c. Vaccines and Drugs 30. Granuloma Inguinale a. Background b. Diagnostic Tests c. Vaccines and Drugs 31. Hantavirus a. Background 0 Identification of the Agent 0 Transmission 0 Other Rodent Hantaviruses 0 Distribution 0 Hantavirus Diseases 0 Epidemiology 0 Addendum in Proof-Northeastern Connection 0 Previously Unknown Pathogens 0 Cases Nationwide b. Diagnostic Tests 0 An Immunohistochemistry Approach 0 Hantavirus Rapid Diagnostic Test 0 ELISA Diagnosis of Hantavirus Pulmonary Syndrome

Future US Microbiology Testing Market Outlook (From Issuu)

Page 6/28


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! 0 IgG ELISA 0 IgM Capture ELISA c. Vaccines and Drugs 32. Helicobacter Pylori a. Background 0 Pathogenesis 0 Role in Peptic Ulcer Disease 0 Role in Gastric Cancer 0 Nonulcer Dyspepsia b. Diagnostic Tests c. Vaccines and Drugs 0 Specific Therapeutic Regimens 0 Who Should Be Treated' 0 Participants in Controlled Clinical Trials 0 Patients with Refractory Peptic Ulcer 0 Patients with Refractory NUD 0 Patients in High-Risk Groups for Gastric Cancer 33. Hepatitis a. Background b. Hepatitis A c. Hepatitis B d. Hepatitis C 0 Classification 0 Transmission of Infection 0 Occupational Hazards 0 Acute Hepatitis 0 Diagnosis of Acute Infection 0 Chronic Hepatitis 0 HCV and Other Chronic Liver Diseases 0 Alcoholic Liver Disease 0 Hepatitis B Coinfection 0 Cirrhosis and Hepatocellular Carcinoma 0 Diagnostic Tests 0 Possible Indications for HCV RNA Testing 0 Conclusions and Future Direction e. Hepatitis D 0 Historical Perspective 0 Epidemiology 0 HBV-HDV "Coinfection" vs. "Superinfection" 0 Methods of Detecting HDV 0 Prevention f. Hepatitis E 0 Background 0 Prevalence of the Disease 0 Diagnostic Tests 0 Epidemiologic Serosurveys

Future US Microbiology Testing Market Outlook (From Issuu)

Page 7/28


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! 0 Serologic Cross-Reactivity g. Hepatitis G 0 Vaccines and Drugs 34. Herpes Simplex Virus a. Background b. Diagnostic Tests c. Vaccines and Drugs 35. Human Herpes Virus-6 (HHV-6) a. Background 0 HIV-6 Infections b. Diagnostic Tests c. Vaccines and Drugs 36. Influenza Viruses a. Background b. Diagnostic Tests c. Vaccines and Drugs 37. Legionella a. Background b. Diagnostic Tests c. Vaccines and Drugs 38. Lyme Disease a. Background 0 Clinical Description 0 Clinical Case Definition 0 Laboratory Criteria for Diagnosis 0 Case Classification b. Diagnostic Tests c. Vaccines and Drugs 39. Lymphogranuloma Venereum (LGV) a. Background b. Diagnostic Tests c. Vaccines and Drugs 40. Malaria a. Background b. Diagnostic Tests 0 Potential Diagnositic Problems with Positive Patients from Non-endemic Areas - Patient - Laboratory - Physician c. Vaccines and Drugs 41. Measles (Rubeola) a. Background b. Diagnostic Tests c. Vaccines and Drugs 42. Meningitis

Future US Microbiology Testing Market Outlook (From Issuu)

Page 8/28


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! a. Background b. Diagnostic Tests c. Vaccines and Drugs 0 Development of Polysaccharide Vaccines 0 Quadrivalent Vaccine Development 0 Meningococcal A.C.Y. & W-135 Vaccines 0 Efficacy of Group C Vaccine 0 Efficacy of Group A Vaccine 0 Combinations of Group A and C Vaccines 0 Group B Efficacy Trials 0 Future Direction 43. Microsporidium a. Background 0 Prevalence and Geographic Distribution 0 Sources of Human Infection and Transmission b. Diagnostic Tests 0 Light Microscopic Examination of Stool Specimens By Chromotrope Staining 0 Stool Concentration Methods 0 Chemofluorescent Agents 0 Giemsa Staining of Stool Specimens 0 Cytologic Diagnosis 0 Histologic Examination 0 Electron Microscopy 0 Examination of Bodily Fluids 0 Examination of Tissue Sections 0 Immunofluorescence Detection Procedures 0 Serology 0 Cell Culture 0 Approach to Diagnosis 0 Evaluation of Patients with Presumptive Intestinal Microsporidiosis 0 Evaluation of Patients with Presumptive Ocular Microsporidiosis c. Vaccines and Drugs 44. Mononucleosis a. Background b. Diagnostic Tests c. Vaccines and Drugs 45. Mumps a. Background b. Diagnostic Tests c. Vaccines and Drugs 0 Efficacy of Vaccination 0 Future Issues 46. Mycoplasma a. Background

Future US Microbiology Testing Market Outlook (From Issuu)

Page 9/28


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! 0 Ureaplasma Urealyticum & Mycoplasma Hominis b. Diagnostic Tests c. Vaccines and Drugs 47. Papillomaviruses a. Background 0 HPV in Cancer 0 Cervical Neoplasm b. Diagnostic Tests c. Vaccines and Drugs 0 Prevention 48. Parvovirus B19 a. Background b. Diagnostic Tests c. Vaccines and Drugs 49. Pneumonia a. Background b. Diagnostic Tests c. Vaccines and Drugs 50. Polyomaviruses a. Background b. Diagnostic Tests c. Vaccines and Drugs 51. Pseudomonas Aeruginosa a. Background 0 Virulence Factors b. Diagnostic Tests c. Vaccines and Drugs 52. Rabies a. Background b. Diagnostic Tests c. Vaccines and Drugs 53. Respiratory Syncytial Virus (RSV) a. Background b. Diagnostic Tests c. Vaccines and Drugs 54. RhinoViruses a. Background b. Diagnostic Tests c. Vaccines and Drugs 55. RotaVirus (REOVIRUS) a. Background b. Diagnostic Tests c. Vaccines and Drugs 56. Rubella(MEASLES) a. Background b. Diagnostic Tests c. Vaccines and Drugs

Future US Microbiology Testing Market Outlook (From Issuu)

Page 10/28


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! 0 Developing Countries 0 Elimination and Eradication of Measles 0 New Developments 57. Salmonellosis a. Background b. Diagnostic Tests c. Vaccines and Drugs 58. Septicemia a. Background b. Diagnostic Tests c. Vaccines and Drugs 59. Shigellosis a. Background b. Diagnostic Tests c. Vaccines and Drugs 60. Staphylococcus Aureus a. Background 0 The Genus Taphylococcus b. Diagnostic Tests c. Vaccines and Drugs 0 Prevention 61. Streptococci a. Background b. Diagnostic Tests c. Vaccines and Drugs 0 Group A Streptococci 0 Group B Streptococci 62. Syphilis a. Background b. Diagnostic Tests 0 Biopsy 0 Rabbit Infectivity Testing 0 Other Diagnostic Modalities c. Vaccines and Drugs 0 Syphilis and HIV Infection 0 Syphilis As a Cofactor for HIV Transmission 0 Basic Science Issues 63. Toxoplasmosis a. Background b. Diagnostic Tests c. Vaccines and Drugs 64. Trichomonas Vaginalis a. Background b. Diagnostic Tests c. Vaccines and Drugs 65. Tuberculosis a. Background

Future US Microbiology Testing Market Outlook (From Issuu)

Page 11/28


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! b. Diagnostic Tests 0 Microscopic Characteristics 0 Cultural Characteristics 0 Detection of Antibodies 0 Skin Tests 0 MDRTB c. Vaccines and Drugs 66. Vibrio a. Background b. Diagnostic Tests c. Vaccines and Drugs 67. West Nile Virus a. Background - Clinical Syndromes b. Diagnostic Tests c. Vaccines and Drugs 68. Yersina a. Background b. Diagnostic Tests c. Vaccines and Drugs B. Instrumentation Review and Market Needs 0 Abbott AxSYM 0 Abbott IMx/IMx Select 0 Anagen AN2000/AuraFlex 0 Beckman Coulter Access 0 BioChem Pharma/SR1 0 BioMerieux/Vitek Vidas 0 Biotrol System 7000 0 Chiron ACS: Centaur 0 Chiron ACS: 180 0 J&J Diagnostics/Amersham Amerlite 0 J&J Diagnostics Vitros ECi 0 Olympus PK310 0 Roche Cobas Core 0 Roche Elecsys 1010/2010 0 Roche ES 22 0 Roche ES 33 0 Roche ES 300/300AL 0 Siemens ELISA Processor II/III 0 Siemens Immuno 1 0 Siemens/Opus/Plus/Magnum 0 Siemens Stratus 0 Tosoh AIA-1200/1200DX/NexIA/600 0 Wallac/Pharmacia Delfia C. Emerging Diagnostic Technologies 1. DNA Probes a. Technology Overview

Future US Microbiology Testing Market Outlook (From Issuu)

Page 12/28


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! b. Amplification Methods 0 Polymerase Chain Reaction - Robotics - Temperature Cyclers - PCR Variations 0 Immuno-PCR 0 QC-PCR 0 DAP-PCR 0 Ligase Chain Reaction 0 Branched DNA 0 Q-Beta Replicase 0 Nucleic-Acid Sequence-Based 0 Strand Displacement Activation 0 Self-Sustained Sequence Replicase 2. Monoclonal Antibodies 3. Immunoassays a. Technological Principle b. Enzyme Immunoassays (EIA) 0 Overview 0 ELISA 0 Dot Immunobinding Assays 0 Capillary Immunoassays 0 Particle-Membrane Capture Immunoassays 0 Enzyme Amplification c. Fluorescent Immunoassays 0 Fluorescence Polarization 0 Time-Resolved Pulse Fluorescence d. Luminescence 0 Chemiluminescence 0 Bioluminescence e. Latex Agglutination f. Immunoprecipitation 4. Differential Light Scattering 5. Microcomputers and Automation 6. Artificial Intelligence 7. Liposomes 8. Flow Cytometry 9. Chromatography 10. MRI 11. Gel Microdroplets 12. Other D. Personal Testing E. Worldwide Business Environment F. Worldwide Market Structure G. Worldwide Market Size and Growth

Future US Microbiology Testing Market Outlook (From Issuu)

Page 13/28


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! U.S.A. A. Executive Summary B. Business Environment 1. Health Care Expenditures 2. Cost Consciousness 3. Reimbursement 4. Industry Consolidation 5. Managed Care a. HMO b. PPO 6. Hospitals 7. Admissions 8. Length of Stay 9. Industry Diversification 10. Physician Demographics 11. Population Aging a. Chronic Illness b. Disease Incidence c. Susceptibility to Iatrogenesis d. Multiple Illness Cases 12. Laboratory Regulations 13. FDA Reform C. Market Structure 1. Centralized Testing a. Hospitals b. Commercial/Private Laboratories c. Blood Banks 1) Community and Regional Centers 2) Plasma Fractionation Centers 2. Decentralized Testing a. Physician Offices/Group Practices b. Point of Care Testing c. Other Decentralized Testing Locations D. Market Size, Growth and Major Suppliers Major Product Development Opportunities A. Instrumentation B. Reagent Kits and Test Systems/Panels C. Computers, Software and Automation D. Auxiliary Products Design Criteria for Decentralized Testing Products Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts D. Distribution Strategies for Decentralized Testing Markets 1. Marketing Approaches

Future US Microbiology Testing Market Outlook (From Issuu)

Page 14/28


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! 2. Product Complexity 3. Customer Preference 4. Established Suppliers 5. Emerging Suppliers 6. Major Types of Distributors 7. Market Segmentation Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection F. Regulatory Constraints G. Decentralized Testing Market Challenges Competitive Assessments - Abbott - Affymetrix - Beckman Coulter - Becton Dickinson - bioMerieux - Bio-Rad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Fujirebio - Gen-Probe - Hologic - ID Biomedical - J&J Diagnostics - Kreatech - Life Technology - Lonza - Nanogen - Novartis Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - Thermo Fisher - Wallac - Wako

Future US Microbiology Testing Market Outlook (From Issuu)

Page 15/28


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! List of Tables Major Companies Developing or Marketing AIDS Tests Major Companies Developing or Marketing Adenovirus Tests Major Companies Developing or Marketing Bartonella Tests Major Companies Developing or Marketing Campylobacter Tests Major Companies Developing or Marketing Candida Tests Major Companies Developing or Marketing Chlamydia Tests Major Companies Developing or Marketing Clostridium Tests Major Companies Developing or Marketing Coronavirus Tests Major Companies Developing or Marketing Cryptosporidium Tests Major Companies Developing or Marketing CMV Tests Major Companies Developing or Marketing Echovirus Tests Major Companies Developing or Marketing Enterovirus Tests Major Companies Developing or Marketing EBV Tests Major Companies Developing or Marketing Giardia Tests Major Companies Developing or Marketing Gonorrhea Tests Major Companies Developing or Marketing Hantavirus Tests Major Companies Developing or Marketing Helicobacter Pylori Tests Major Companies Developing or Marketing Hepatitis Tests Major Companies Developing or Marketing Herpes Tests Major Companies Developing or Marketing Influenza Tests Major Companies Developing or Marketing Legionella Tests Major Companies Developing or Marketing Lyme Disease Tests Major Companies Developing or Marketing Lymphogranuloma Tests Major Companies Developing or Marketing Malaria Tests Major Companies Developing or Marketing Measles

Future US Microbiology Testing Market Outlook (From Issuu)

Page 16/28


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! Tests Major Companies Developing or Marketing Meningitis Tests Major Companies Developing or Marketing Microsporidium Tests Major Companies Developing or Marketing Mononucleosis Tests Major Companies Developing or Marketing Mumps Tests Major Companies Developing or Marketing Mycoplasma Tests Major Companies Developing or Marketing Papilloma Virus Tests Major Companies Developing or Marketing Parvovirus Tests Major Companies Developing or Marketing Pneumonia Tests Major Companies Developing or Marketing RSV Tests Major Companies Developing or Marketing Rotavirus Tests Major Companies Developing or Marketing Rubella Tests Major Companies Developing or Marketing Salmonella Tests Major Companies Developing or Marketing Septicemia Tests Major Companies Developing or Marketing Shigella Tests Major Companies Developing or Marketing Staphylococci Tests Major Companies Developing or Marketing Streptococci Tests Major Companies Developing or Marketing Syphilis Tests Major Companies Developing or Marketing Toxoplasmosis Tests Major Companies Developing or Marketing Trichomonas Tests Major Companies Developing or Marketing Tuberculosis Tests Major Companies Developing or Marketing West Nile Tests Major Companies Developing or Marketing Yersinia Tests Worldwide All Market Segments Laboratories Performing Microbiology Tests by Country Worldwide All Market Segments Total Microbiology Test Volume Forecast by Country

Future US Microbiology Testing Market Outlook (From Issuu)

Page 17/28


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! Worldwide All Market Segments Total Microbiology Diagnostics Market Forecast by Country Infectious Disease Tests Major Issues and Market Potential For Personal Testing U.S.A. Summary Table All Infectious Diseases Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Laboratories Performing Infectious Disease Tests by Market Segment U.S.A. Hospital Laboratories Performing Infectious Disease Tests by Bed Size U.S.A. Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test Volume U.S.A. Physician Office Laboratories Performing Infectious Disease Tests by Practice Size U.S.A. All Market Segments Infectious Disease Test Volume Forecast U.S.A. Hospital Laboratories Infectious Disease Test Volume Forecast U.S.A. Blood Banks Infectious Disease Test Volume Forecast U.S.A. Physician Office Laboratories Infectious Disease Test Volume Forecast U.S.A. Commercial/Private Laboratories Infectious Disease Test Volume Forecast U.S.A. Public Health Laboratories Infectious Disease Test Volume Forecast U.S.A. All Market Segments Infectious Disease Diagnostics Market Forecast U.S.A. Hospital Laboratories Infectious Disease Diagnostics Market Forecast U.S.A. Blood Banks Infectious Disease Diagnostics Market Forecast U.S.A. Physician Office Laboratories Infectious Disease Diagnostics Market Forecast U.S.A.

Future US Microbiology Testing Market Outlook (From Issuu)

Page 18/28


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast U.S.A. Public Health Laboratories Infectious Disease Diagnostics Market Forecast U.S.A. HIV or HIVI/HIVII Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. HIVAg Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Aeromonads Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. BEA Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Candida Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Coronavirus Test Volume and Diagnostics Sales Forecast by

Future US Microbiology Testing Market Outlook (From Issuu)

Page 19/28


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! Market Segment U.S.A. CoxsackieVirus Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. CMV Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Echovirus Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. EBV Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Giardia Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Hantavirus Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A.

Future US Microbiology Testing Market Outlook (From Issuu)

Page 20/28


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. HbsAg Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Anti-HBC Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Anti-HBS Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. HBcAg Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. HBeAg Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Influenza Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Legionella Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment

Future US Microbiology Testing Market Outlook (From Issuu)

Page 21/28


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! U.S.A. Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Malaria Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Measles Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Meningitis Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Microsporidium Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Mumps Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Papilloma Virus Test Volume and Diagnostics Sales Forecast by Market Segment U.s.a. Parvovirus Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Polyomaviruses Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Pseudomonas Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Rabies Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. RSV Test Volume and Diagnostics Sales Forecast by Market Segment

Future US Microbiology Testing Market Outlook (From Issuu)

Page 22/28


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! U.S.A. Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Rubella Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Septicemia Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Shigella Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Staphylococci Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Streptococci Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Trichomonas Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. West Nile Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Yersinia Test Volume and Diagnostics Sales Forecast by

Future US Microbiology Testing Market Outlook (From Issuu)

Page 23/28


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! Market Segment U.S.A. AIDS Testing Market Diagnostics Sales by Major Supplier U.S.A. Adenovirus Testing Market Diagnostics Sales by Major Supplier U.S.A. Campylobacter Testing Market Diagnostics Sales by Major Supplier U.S.A. Candida Testing Market Diagnostics Sales by Major Supplier U.S.A. Chancroid Testing Market Diagnostics Sales by Major Supplier U.S.A. Chlamydia Testing Market Diagnostics Sales by Major Supplier U.S.A. CMV Testing Market Diagnostics Sales by Major Supplier U.S.A. Cryptosporidium Testing Market Diagnostics Sales by Major Supplier U.S.A. Echovirus Testing Market Diagnostics Sales by Major Supplier U.S.A. Enterovirus Testing Market Diagnostics Sales by Major Supplier U.S.A. EBV Testing Market Diagnostics Sales by Major Supplier U.S.A. Giardia Testing Market Diagnostics Sales by Major Supplier U.S.A. Gonorrhea Testing Market Diagnostics Sales by Major Supplier U.S.A. Helicobacter Pylori Testing Market Diagnostics Sales by Major Supplier U.S.A. Hepatitis Testing Market Diagnostics Sales by Major Supplier

Future US Microbiology Testing Market Outlook (From Issuu)

Page 24/28


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! U.S.A. Hepatitis C Testing Market Diagnostics Sales by Major Supplier U.S.A. Herpes Testing Market Diagnostics Sales by Major Supplier U.S.A. Influenza Testing Market Diagnostics Sales by Major Supplier U.S.A. Legionella Testing Market Diagnostics Sales by Major Supplier U.S.A. Lyme Disease Testing Market Diagnostics Sales by Major Supplier U.S.A. Measles Testing Market Diagnostics Sales by Major Supplier U.S.A. Meningitis Testing Market Diagnostics Sales by Major Supplier U.S.A. Mononucleosis Testing Market Diagnostics Sales by Major Supplier U.S.A. Mumps Testing Market Diagnostics Sales by Major Supplier U.S.A. Mycoplasma Testing Market Diagnostics Sales by Major Supplier U.S.A. Pneumonia Testing Market Diagnostics Sales by Major Supplier U.S.A. Rabies Testing Market Diagnostics Sales by Major Supplier U.S.A. RSV Testing Market Diagnostics Sales by Major Supplier U.S.A. Rotavirus Testing Market Diagnostics Sales by Major Supplier U.S.A. Rubella Testing Market Diagnostics Sales by Major Supplier U.S.A. Salmonella Testing Market Diagnostics Sales by

Future US Microbiology Testing Market Outlook (From Issuu)

Page 25/28


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! Major Supplier U.S.A. Septicemia Testing Market Diagnostics Sales by Major Supplier U.S.A. Shigella Testing Market Diagnostics Sales by Major Supplier U.S.A. Streptococci Testing Market Diagnostics Sales by Major Supplier U.S.A. Syphilis Testing Market Diagnostics Sales by Major Supplier U.S.A. Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier

Future US Microbiology Testing Market Outlook (From Issuu)

Page 26/28


Find Industry reports, Company profiles and Market Statistics

ReportLinker

>> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: ƒ ƒ

Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93

If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information Please verify that the product information is correct and select the format(s) you require. Future US Microbiology Testing Market Outlook

Product Formats Please select the product formats and the quantity you require. Local PDF--USD 9 400.00

Quantity: _____

Global PDF--USD 19 700.00

Quantity: _____

Contact Information Please enter all the information below in BLOCK CAPITALS

Title:

Mr

Mrs

Dr

Miss

Ms

Prof

First Name:

_____________________________ Last Name: __________________________________

Email Address:

__________________________________________________________________________

Job Title:

__________________________________________________________________________

Organization:

__________________________________________________________________________

Address:

__________________________________________________________________________

City:

__________________________________________________________________________

Postal / Zip Code:

__________________________________________________________________________

Country:

__________________________________________________________________________

Phone Number:

__________________________________________________________________________

Fax Number:

__________________________________________________________________________

Future US Microbiology Testing Market Outlook (From Issuu)

Page 27/28


Find Industry reports, Company profiles and Market Statistics

ReportLinker

>> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card

Card Number: ______________________________________________

Expiry Date

__________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer

Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check

UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

 

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms

Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56

ƒ ƒ

Asia, Oceania and America : + 1 (805) 617 17 93

Future US Microbiology Testing Market Outlook (From Issuu)

Page 28/28


Future US Microbiology Testing Market Outlook